Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Adaptimmune Therapeutics PLC | 1,612,032 | reported | 20 Feb 2025 | tx 9+8,210,688 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Feb 2025 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 1,074,696 | 0.00 USD | deriv |
| 20 Feb 2025 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 1,612,032 | 0.00 USD | deriv |
| 15 Jan 2024 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 2,544,432 | 0.00 USD | deriv |
| 15 Jan 2024 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 565,416 | 0.00 USD | deriv |
| 17 Jan 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 135,480 | 0.00 USD | deriv |
| 17 Jan 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 314,256 | 0.00 USD | deriv |
| 17 Jan 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 1,407,072 | 0.00 USD | deriv |
| 04 May 2022 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 333,792 | 0.00 USD | deriv |
| 04 May 2022 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 223,512 | 0.00 USD | deriv |